Cancer

Cancer refers to a group of more than a hundred diseases that can originate in many different parts of the body. Cancer begins in your cells, which are the building blocks of your body.

Metabolic Flexibility in Cancer: How Diet and Nutrition Shape Tumor Survival and Resistance

Cancer cells survive therapy by dynamically rewiring their metabolism in response to nutrient availability, microenvironmental stress, and therapeutic pressure. This article explains how dietary interventions may exploit metabolic flexibility and plasticity to enhance treatment response while accounting for tumor heterogeneity.

Cancer Epidemiology

Secondary Lung Cancer

Cancer Prognosis

Is Cancer a Metabolic Disorder?

What Role do Biobanks Play in Cancer Research?

What is Cancer of Unknown Primary?

Hypoxia Markers and Their Importance

CDK9 and Cancer

What is Immunochemotherapy?

Microfluidic cancer treatment screen combined with flow cytometry

Investigating the Molecular Mechanisms of Cancer

See more featured articles »

Pediatric Cancer

TARDIS: The Improved Method of Detecting Breast Cancer

Caring for a Loved One with Cancer

Cancer Pathophysiology

Cancer Research

Exploiting Enzymes in Cancer Diagnosis and Therapy

Cancer Management

Transforming Cancer Care through Genomic Testing

Living with Cancer Pain

Why are Cancer Cell Lines Useful?

How Camomile Could Prevent Neutropenia in Pediatric Leukemia Patients

Cancer Symptoms

Cancer Glossary

Cancer Screening Considerations: Balancing the Benefits and Risks

Insights into Oncofertility

What is Merkel Cell Carcinoma?

Insight into Cancer Vaccines

Acidosis and Tumor Progression

British Pioneers in Cancer Biology

Cancer Prevention: Lowering your Risk

Extracellular Vesicles as Floating Cancer Biomarkers

The Biochemistry of Breast Cancer Screening

What is Cancer?

What is the Tumor Microenvironment?

Cancer History

Tyrosine Kinase Inhibitors for Targeted Cancer Therapy

Overview of Cell Viability and Cytotoxicity

Targeted Cancer Therapies

Cancer Plasticity: The Shape-Shifting Threat Challenging Modern Treatments

Proto-Oncogene Activation: The Genetic Shift that Fuels Cancer

Secondary Brain Cancer

Cancer Classification

Metastatic Migration in Cancer may be Influenced by Metabolism

Hot vs Cold: the differences between tumor types

The Cancer Cell Surface Proteome as a Therapeutic Target

Cured Meats, Nitrates, and Cancer Risk: Why Food Source and Processing Matter

Cutaneous Manifestations of Internal Malignancy

The Effects of Cancer on Family Life

Effects of Social and Economic Deprivation on Cancer Mortality

How Immune Checkpoint Inhibitors have Revolutionized Cancer Treatment

Using Biomarkers to Detect Cancer

What is Tumorigenesis?

Myc Mutations and Cancer

Discovery of Blood Cancer Cells that show Plasma Cell-Like Differentiation

What Causes Cancer?

Cancer Pain

Nanostructured toxins for the selective destruction of drug-resistant human CXCR4style+ colorectal cancer stem cells

Cancer Pain Management

Assay for Monitoring and Treating Malignant Brain Tumors

Cancer Diagnosis

Latest Cancer News and Research

Yourgene Health launches Insight DPYD assay (IVDR)

Yourgene Health (part of the Novacyt Group), an international molecular diagnostics company with a broad portfolio of integrated technologies and services, announces the commercial launch of its In Vitro Diagnostic Regulation (IVDR)-certified Yourgene® Insight DPYD assay, expanding the Company's clinical genetics portfolio across regulated European markets.

From Yourgene Health 9 Sep 2026

Chaotic tumor environments may trigger cancer cell invasion

In 2024, malignant tumors caused more than 21,300 deaths in Austria, 4.7% more than in 2014. Faced with a similarly pressing global challenge, scientists are striving to better understand what drives cancer cells to grow, spread, and invade healthy tissue.

9 Sep 2026

Study reveals processes driving DNA damage in prostate cancer

Cancer begins with errors in the DNA inside our cells, and those errors are often more complicated than a handful of mutated genes.

9 Sep 2026

Protein-based MRI agent detects tiny lung cancer metastases

A multi-institutional research team led by Georgia State University Regents' Professor Emerita of Biochemistry and Biophysical Chemistry Jenny J. Yang has developed a new class of protein-based MRI contrast agent that detects invasive lung cancer and metastatic disease at earlier stages than conventional imaging approaches.

9 Sep 2026

Study links methylglyoxal stress to immunotherapy resistance in triple-negative cancer

The metabolism of cancer cells may play a key role in their ability to evade the immune system. This is demonstrated by a new study conducted by researchers at the University of Liège, which reveals how methylglyoxal stress – a by-product of tumor metabolism – promotes immunosuppression and the formation of metastases, and may contribute to resistance to immunotherapy and the progression of triple-negative cancer.

9 Sep 2026

New genetic map helps track aggressive prostate cancer development

Prostate cancer is the second most common form of cancer among men globally. Yet, we still know relatively little about why the disease develops or why some men live with it for years while in others it progresses aggressively.

9 Sep 2026

New genomic language AI model excels in predicting the pathogenicity of genetic variants

More than two decades after scientists first sequenced the entire human genome - all 3 billion "letters," or base pairs, of DNA code - the meaning of much of this code remains a mystery.

9 Sep 2026

Caloric restriction reduces genetic mutations across the mouse genome

Mutations are changes in the molecular "letters" that make up DNA, the genetic blueprint for cells. Mutations build up with age in every cell when DNA is damaged or when cells make mistakes in fixing or copying it.

9 Sep 2026

Study shows how the microbiome shapes lung cancer immunotherapy outcomes

Despite the revolutionary impact of immune checkpoint inhibitors on cancer therapy, 60% to 80% of patients with NSCLC still show suboptimal responses.

9 Sep 2026

New laser-fabricated plasmonic chip accurately identifies and sorts cancer cells

Novel laser-fabricated plasmonic chip combines 185 nm Raman resolution and deep learning to identify and sort cancer cells with 96.2% accuracy.

9 Sep 2026

New integrated framework advances precision surgery for liver cancer

Hepatocellular carcinoma is the sixth most common malignancy and the third leading cause of cancer-related death globally.

9 Sep 2026

New AI method tracks immune responses without known antibody databases

A research team comprising Associate Professor FUNAKOSHI Yohei, Associate Professor YAKUSHIJIN Kimikazu, Professor MINAMI Hironobu, and Associate Professor OHJI Goh of Kobe University, together with graduate student MASUDA Genki, then-graduate student IIZUMI Shunsuke, Associate Professor OHUE Masahito, and colleagues at the Institute of Science Tokyo, has developed a new analysis method, LM-QASAS.

9 Sep 2026

Is stroke risk higher after a cancer diagnosis?

New research indicates that people with invasive cancer face an elevated risk of experiencing a stroke, especially in the first few months after diagnosis and especially if they have certain types of cancer.

9 Sep 2026

AlphaGenome Atlas maps billions of genetic changes with AI

The human genome contains approximately 3 billion DNA letters, creating more than 9 billion possible single-letter changes.

9 Sep 2026

UCLA researchers develop scalable TCR therapy for solid tumors

T cell receptor, or TCR, therapy is a cancer treatment that genetically reprograms immune cells, called T cells, to hunt down cancer with precision. It's similar to another treatment, CAR T-cell therapy, but with one key difference: CAR T-cell therapy can only spot proteins that naturally appear outside of a cancer cell.

8 Sep 2026

New AI tool automates colonoscopy quality assessment at scale

Colonoscopies are one of the most effective ways to prevent colorectal cancer, which is surging among young adults in the U.S. Yet, the quality of each procedure can vary substantially from one physician to another.

8 Sep 2026

Helicobacter pylori exposure linked to one in five cases of bowel cancer

Exposure to the stomach microbe Helicobacter pylori may be associated with more than 1 in 5 cases of bowel cancer worldwide, suggests an exploratory risk attribution study, published in the open access journal eGastroenterology.

8 Sep 2026

COVID-19 linked to lower subsequent risk of type 1 diabetes

New research to be presented at the Annual Meeting of The European Association for the Study of Diabetes (EASD) in Milan, Italy (Sept 28 – Oct 2) shows that people who have had COVID-19 have a lower, rather than higher, risk of subsequent development of type 1 diabetes (T1D).

8 Sep 2026

Hormone therapy during menopause transition associated with lower heart disease risk

A study led by Virginia Commonwealth University and the University of Pittsburgh provides pivotal insights into one of the most debated questions in women's health: how does hormone therapy for menopause symptoms affect cardiovascular disease risk when used in peri- or early postmenopause?

8 Sep 2026

Working shifts may change more than your sleep schedule

A cross-sectional analysis of 1,814 Japanese workers found that shift work was associated with lower raw seafood intake and shorter sleep patterns in both sexes, while female shift workers also consumed less milk and dairy products. Total energy intake was similar between work groups, but male shift workers were more likely to consider preference and convenience when choosing foods, highlighting potentially important differences in dietary quality and lifestyle rather than calorie intake.

8 Sep 2026